Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Glenmark gets USFDA nod for generic skin ointment

      Glenmark gets USFDA nod for generic skin ointment

      Ruby Khatun Khatun25 Aug 2017 10:45 AM IST
      New Delhi: Glenmark Pharmaceuticals on Wednesday said it has received final approval from the US health regulator for generic Triamcinolone Acetonide...
      USFDA clears marketing of Zydus Cadila anti-hypertension drug

      USFDA clears marketing of Zydus Cadila anti-hypertension drug

      Ruby Khatun Khatun25 Aug 2017 10:30 AM IST
      New Delhi: Zydus Cadila has received final approval from the US health regulator to market candesartan cilexetil tablets used for the treatment of...
      Novartis receives EU approval for breast cancer drug Kisqali

      Novartis receives EU approval for breast cancer drug Kisqali

      Ruby Khatun Khatun25 Aug 2017 10:30 AM IST
      ZURICH: Novartis AG said its drug Kisqali (ribociclib) received European Union approval as first-line treatment for a tough-to-treat breast cancer,...
      Roche says FDA grants priority review to hemophilia drug emicizumab

      Roche says FDA grants priority review to hemophilia drug emicizumab

      Ruby Khatun Khatun25 Aug 2017 10:00 AM IST
      ZURICH: Swiss pharma group Roche said the U.S. Food and Drug Administration (FDA) granted priority review to its emicizumab for hemophilia A with...
      Fujifilm aims to double revenues in India by 2020

      Fujifilm aims to double revenues in India by 2020

      Ruby Khatun Khatun25 Aug 2017 9:30 AM IST
      Chennai: Fujifilm India, a wholly owned subsidiary of Japan-based Fujifilm Holdings Corporation, is aiming to more than double revenues by 2020, on...
      Law Ministry Rejects Pharma Marketing Rules

      Law Ministry Rejects Pharma Marketing Rules

      Ruby Khatun Khatun24 Aug 2017 1:22 PM IST
      MUMBAI: India's plan to bring in marketing rules to curb unethical promotional practices in the country's drug industry faces an indefinite delay...
      Dr Reddys out-licenses steroid DFD-06 to Encore Dermatology

      Dr Reddys out-licenses steroid DFD-06 to Encore Dermatology

      Ruby Khatun Khatun24 Aug 2017 11:00 AM IST
      New Delhi: Drug major Dr Reddy's Laboratories on Tuesday said it has out-licensed the future development, manufacturing and commercialisation rights...
      Rekha Jhunjhunwala buys Fortis Healthcare shares worth Rs 60 crore

      Rekha Jhunjhunwala buys Fortis Healthcare shares worth Rs 60 crore

      Ruby Khatun Khatun24 Aug 2017 10:30 AM IST
      New Delhi: Ace investor Rakesh Jhunjhunwala's wife Rekha picked up 45 lakh shares of Fortis Healthcare for an estimated Rs 60 crore through an open...
      Zydus Cadila gets final USFDA nod for Pindolol tablets

      Zydus Cadila gets final USFDA nod for Pindolol tablets

      Ruby Khatun Khatun24 Aug 2017 10:30 AM IST
      New Delhi: Drug firm Zydus Cadila on Tuesday said it has received final approval from the US health regulator to market Pindolol tablets, used for the...
      Eisai Pharma launches first-in-class epilepsy treatment Fycompa (Perampanel) in India

      Eisai Pharma launches first-in-class epilepsy treatment Fycompa (Perampanel) in India

      Ruby Khatun Khatun24 Aug 2017 10:00 AM IST
      Eisai Pharmaceuticals India Pvt. Ltd, a leading Japanese pharmaceutical company announced the launch of Fycompa (perampanel), a new anti-epileptic...
      Medtronic misses revenue estimates, shares dip

      Medtronic misses revenue estimates, shares dip

      Ruby Khatun Khatun24 Aug 2017 9:30 AM IST
      Medical device maker Medtronic Plc on Tuesday reported quarterly revenue fell short of analysts' estimates, hurt by lower sales in its...
      Shire CFO resigns to join plant technology start-up

      Shire CFO resigns to join plant technology start-up

      Ruby Khatun Khatun24 Aug 2017 9:00 AM IST
      LONDON: Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok